MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in MoonLake Immunotherapeutics as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +4 vs. Q2 2025
- Shares held
- 37.6M
- −21.1M (−36.0%) vs. Q2 2025
- Total value
- $269.7M
- −$2.50B (−90.3%) vs. Q2 2025
- New holders
- 49
- 33 more added
- Sold out
- 45
- 41 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TD Asset Management Inc | 106,610 | $764.4K | 0.00% | −79,542−42.7% | Reduced |
| Vanguard Group Inc | 120,243 | $862.1K | 0.00% | −626−0.5% | Reduced |
| BlackRock, Inc. | 125,381 | $899.0K | 0.00% | −201,961−61.7% | Reduced |
| Pictet Asset Management Holding SA | 131,991 | $946.4K | 0.00% | −15,730−10.6% | Reduced |
| Catalio Capital Management, LP | 133,131 | $954.5K | 0.18% | −29,465−18.1% | Reduced |
| Candriam Luxembourg S.C.A. | 133,642 | $958.2K | 0.01% | −11,188−7.7% | Reduced |
| Rice Hall James & Associates, LLC | 134,835 | $966.8K | 0.05% | −7,485−5.3% | Reduced |
| Clearbridge Investments, LLC | 135,496 | $971.5K | 0.00% | +107,069+376.6% | Added |
| HRT Financial LP | 143,275 | $1.03M | 0.00% | +143,275 | New |
| ADAR1 Capital Management, LLC | 151,495 | $1.09M | 0.11% | +117,181+341.5% | Added |
| Schroder Investment Management Group | 195,490 | $1.22M | 0.00% | +176,100+908.2% | Added |
| JPMorgan Chase & Co | 174,161 | $1.25M | 0.00% | +134,764+342.1% | Added |
| Exome Asset Management LLC | 178,084 | $1.28M | 0.84% | +178,084 | New |
| Decheng Capital LLC | 181,600 | $1.30M | 0.23% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 194,741 | $1.40M | 0.00% | +194,741 | New |
| Rhenman & Partners Asset Management AB | 207,000 | $1.48M | 0.16% | +162,000+360.0% | Added |
| Boxer Capital Management, LLC | 250,000 | $1.79M | 0.57% | +250,000 | New |
| Morgan Stanley | 256,655 | $1.84M | 0.00% | +213,416+493.6% | Added |
| Boothbay Fund Management, LLC | 258,779 | $1.86M | 0.05% | +258,779 | New |
| First Turn Management, LLC | 262,643 | $1.88M | 0.28% | +262,643 | New |
| Verition Fund Management LLC | 272,768 | $1.96M | 0.01% | +249,241+1,059.4% | Added |
| Marshall Wace, LLP | 321,109 | $2.30M | 0.00% | −208,102−39.3% | Reduced |
| Goldman Sachs Group Inc | 362,871 | $2.60M | 0.00% | −912,698−71.6% | Reduced |
| Ikarian Capital, LLC | 435,839 | $3.12M | 0.71% | +435,839 | New |
| Two Sigma Investments, LP | 454,268 | $3.26M | 0.01% | +454,268 | New |
| Nuveen, LLC | 635,699 | $4.56M | 0.00% | −155,856−19.7% | Reduced |
| FMR LLC | 726,932 | $5.21M | 0.00% | −5,003,617−87.3% | Reduced |
| Price T Rowe Associates Inc | 822,957 | $5.90M | 0.00% | −1,790,276−68.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 965,405 | $6.92M | 0.05% | +965,405 | New |
| Adage Capital Partners GP, L.L.C. | 1,500,000 | $10.8M | 0.02% | +1,500,000 | New |
| Balyasny Asset Management LLC | 1,699,235 | $12.2M | 0.02% | +1,276,065+301.5% | Added |
| Cormorant Asset Management, LP | 1,994,173 | $14.3M | 0.99% | −6,499,978−76.5% | Reduced |
| Avoro Capital Advisors LLC | 2,000,000 | $14.3M | 0.19% | −2,150,000−51.8% | Reduced |
| BVF Inc | 19,751,284 | $141.6M | 5.74% | 00.0% | Unchanged |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −1,259,376−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,248,573−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −1,138,022−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −878,323−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −741,090−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −675,445−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −508,267−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −313,571−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −295,623−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −290,784−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −282,313−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −247,500−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −246,114−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −148,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −83,839−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −80,362−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −62,318−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −54,416−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −31,714−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −29,662−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,313−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −21,390−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −19,164−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −17,623−100.0% | Sold out |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0 | $0 | 0.00% | −12,790−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −12,565−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −11,949−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −9,585−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −6,960−100.0% | Sold out |
| Glenmede Investment Management, LP | 0 | $0 | 0.00% | −6,635−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −6,428−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −6,338−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −5,971−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −1,565−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −509−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −490−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −24−100.0% | Sold out |